BREAKING
AI Drug Discovery Hits Biology Wall
AI Speeds Front End, Not the Rules
1
Design molecule
↓
2
Safety trials
↓
3
Efficacy in humans
↓
4
FDA approval
0
mo
To candidate
0
Selected
0
Phase II start
0
B
2025 market
0
B
2026 market
0
yr
Approval path
Speed vs Wall Street's Clock
What AI Delivers
●
Faster candidate design
●
Richer pipelines
●
Better front-end optimization
What Remains
●
No AI drug FDA-approved yet
●
High Phase III attrition
●
8 to 12 year approval path
Faster Molecules, Same Finish Line
AI NEWS BLITZ
AI has sped up drug discovery, but human biology and Wall Street's clock still stand in the way.